Skip to main content
. 2022 Nov 2;129(1):107–117. doi: 10.1002/cncr.34509

FIGURE 2.

FIGURE 2

Tumors in patients with hemoglobinopathies: (A) distribution of tumors by gender and (B) distribution of tumors by type of hemoglobinopathy. CNS, Central Nervous System; HbH indicates hemoglobin H; NTDT, non–transfusion‐dependent β‐thalassemia; SCD, sickle cell disease; TDT, transfusion‐dependent β‐thalassemia.